Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2022, 31(5):269-275

Comment on 2021 ESC/EACTS Guidelines on the Management of Valvular Heart Disease

Šimková I1, Valočik G2, Hudec M3
1 Klinika kardiológie a angiológie LF SZU a NÚSCH, a. s., Bratislava
2 I. Kardiologická klinika UPJŠ a VÚSCH, a. s., Košice
3 Oddelenie akútnej kardiológie, II. klinika kardiológie a angiológie LF SZU a SÚSCCH, a. s. Banská Bystrica, Slovenská republika

Published: May 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimková I, Valočik G, Hudec M. Comment on 2021 ESC/EACTS Guidelines on the Management of Valvular Heart Disease. Cardiology Letters. 2022;31(5-6):269-275.
Download citation

References

  1. Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, et al. EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019;140:11561169 Go to original source...
  2. Tribouilloy Ch, Bohbot Y, Kubala M, Ruschitzka F, Popescu B, Wendler O, et al., on behalf of the EORP VHD II Registry Investigators Group. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. Eur Heart J., (2022). https://doi.org/10.1093/eurheartj/ehac209 Go to original source...
  3. Vahanian F, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J., (2021). http://dx.doi.org/10.1093/eurheartj/ehab395. Go to original source...
  4. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563645. https://doi.org/10.1093/eurheartj/ehab484 Go to original source...
  5. Guimarães HP, Lopes RD, de Barros ESPGM, et al. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med. 2020;383:2117-2126. http://dx.doi.org/10.1056/NEJMoa202960. Go to original source...
  6. Shim CY, Seo J, Kim YJ, et al. Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial. J Thorac Cardiovasc Surg. (2021), http://dx.doi.org/10.1016/j.jtcvs.2021.01.127. Go to original source...
  7. Whitlock RP, Belley-Cote EP, Paparella D, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384:2081-2091. http://dx.doi.org/10.1056/NEJMoa2101897 Go to original source...